Author Archives: Warren Woessner

Manhattan March for Science

Posted on April 27, 2017 by Warren Woessner

This following is a recap of the Manhattan March for Science by Robin Chadwick. The March for Science in Manhattan was smaller than the January 2017 Women’s March in Washington, but large enough that the “entry point” for us was changed from 62nd … Continue reading →

Posted in Govt Policy/PTO Policy | 1 Comment

Fairchild (Taiwan) Corp. v. Power Integrations, Inc.

Posted on April 24, 2017 by Warren Woessner

In my last post, I discussed estoppel in the context in inter partes review, in which defendant filed for IPR after losing in the courts. The Board found the claims-in-suit to be obvious. The Federal Circuit affirmed that the courts and … Continue reading →

Posted in Inter Partes Review | Leave a comment

Novartis AG, LTS et al. v. Noven Pharmaceuticals, Inc. – Prior Judicial Opinions Don’t Bind the PTAB

Posted on April 21, 2017 by Warren Woessner

After Novartis’ patents were found nonobvious by the Fed. Cir., affirming the Delaware District Court, defendant Noven filed for inter partes review (IPR) of U.S. Pat. Nos. 6316023 and 6335031, on rivastigmine and an antioxidant. The PTAB found the asserted … Continue reading →

Posted in Inter Partes Review | 1 Comment

Is the Halo Broken Already?

Posted on April 10, 2017 by Warren Woessner

Last week Docket Navigator delivered a troubling headline regarding a recent District Court decision – “Invalidity Opinion Delivered After Product Launch No Defense to Willful Infringement.” As a practitioner who regularly drafts non-infringement and invalidity opinions, this sort of headline … Continue reading →